The Fasting Blood Glucose and Long Non-coding RNA SNHG8 Predict Poor Prognosis in Patients with Gastric Carcinoma After Radical Gastrectomy

Overview

Journal Aging (Albany NY)

Specialty Geriatrics

Date 2018 Oct 10

PMID 30299268

Citations 10

Authors

Yunchai Lin

Dan Hu

Qiang Zhou

Xiandong Lin

Jinxiu Lin

Feng Peng

Affiliations

Soon will be listed here.

Abstract

This prospective study sought to evaluate the prediction of fasting blood glucose and long non-coding RNA (lncRNA) SNHG8 for the risk of gastric carcinoma mortality. A total of 217 gastric carcinoma patients underwent radical gastrectomy were included during 2012-16. The final follow-up was finished in January 2017. The aggregate hazard ratio(HR) demonstrated that poor prognosis of gastric carcinoma was associated with fasting blood glucose (HR= 1.29, P=0.037), SNHG8 expression(HR = 1.10, P= 0.009), positive distant metastasis(HR = 2.99, P= 0.020), EBV positive (HR = 3.40, P=0.002), and tumor size more than 5.0 cm (HR = 3.36, P= 0.005). In survival analysis, elevated fasting blood glucose (P =0.007) and high SNHG8 expression (P =0.007) were significantly associated with shorter survival times in gastric cancer. Significant multiplicative interaction was shown between fasting blood glucose and SNHG8 expression (chi-squared=7.81, P =0.005), without statistical additive interaction. Fasting blood glucose and SNHG8 expression could predict poor prognosis after radical gastrectomy. LncRNA SNHG8 could be applied as a novel epigenetic molecular target in gastric carcinoma.

Citing Articles

Circulating long noncoding RNA, Zfpm2-As1, and XIST based on medical data analysis are potential plasma biomarkers for gastric cancer diagnosis.

Liang H, Li H, Xia N, Chen J, Gao L, Liu H Technol Health Care. 2024; 32(6):4919-4928.

PMID: 38820035 PMC: 11612959. DOI: 10.3233/THC-232033.

LncRNA SNHG8 regulates the migration and angiogenesis of pHUVECs induced by high glucose via the TRPM7/ERK signaling axis.

Fan Z, Chen X, Wang L, Yu J, Zhang S, Xu C Sci Rep. 2023; 13(1):22485.

PMID: 38110485 PMC: 10728107. DOI: 10.1038/s41598-023-49779-7.

Prognostic Implication of EBV Infection in Gastric Carcinomas: A Systematic Review and Meta-Analysis.

Pyo J, Kim N, Kang D Medicina (Kaunas). 2023; 59(5).

PMID: 37241066 PMC: 10221611. DOI: 10.3390/medicina59050834.

[Matrix stiffening related lncRNA SNHG8 regulates chemosensitivity of ovarian cancer].

Cheng Z, Ma X, Zhang Q, Chen W Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2023; 40(1):87-94.

PMID: 36854552 PMC: 9989763. DOI: 10.7507/1001-5515.202205038.

Testing lncRNAs signature as clinical stage-related prognostic markers in gastric cancer progression using TCGA database.

Beeraka N, Gu H, Xue N, Liu Y, Yu H, Liu J Exp Biol Med (Maywood). 2022; 247(8):658-671.

PMID: 35068210 PMC: 9039491. DOI: 10.1177/15353702211067173.

References

Godsland I . Insulin resistance and hyperinsulinaemia in the development and progression of cancer. Clin Sci (Lond). 2009; 118(5):315-32. PMC: 2782313. DOI: 10.1042/CS20090399. View

Qiu H, Yu I, Wang X, Fu Z, Tse S . [Study on the interaction under logistic regression modeling]. Zhonghua Liu Xing Bing Xue Za Zhi. 2009; 29(9):934-7. View

Lindkvist B, Almquist M, Bjorge T, Stocks T, Borena W, Johansen D . Prospective cohort study of metabolic risk factors and gastric adenocarcinoma risk in the Metabolic Syndrome and Cancer Project (Me-Can). Cancer Causes Control. 2012; 24(1):107-16. DOI: 10.1007/s10552-012-0096-6. View

Yau T, Tang C, Yu J . Epigenetic dysregulation in Epstein-Barr virus-associated gastric carcinoma: disease and treatments. World J Gastroenterol. 2014; 20(21):6448-56. PMC: 4047330. DOI: 10.3748/wjg.v20.i21.6448. View

Nakae J, Kido Y, Accili D . Distinct and overlapping functions of insulin and IGF-I receptors. Endocr Rev. 2001; 22(6):818-35. DOI: 10.1210/edrv.22.6.0452. View

Hu J, Song W, Zhang S, Shen X, Qiu X, Wu H . HBx-upregulated lncRNA UCA1 promotes cell growth and tumorigenesis by recruiting EZH2 and repressing p27Kip1/CDK2 signaling. Sci Rep. 2016; 6:23521. PMC: 4806364. DOI: 10.1038/srep23521. View

Salisbury T, Tomblin J . Insulin/Insulin-like growth factors in cancer: new roles for the aryl hydrocarbon receptor, tumor resistance mechanisms, and new blocking strategies. Front Endocrinol (Lausanne). 2015; 6:12. PMC: 4313785. DOI: 10.3389/fendo.2015.00012. View

Lin X, Chen S, Qi Y, Zhu J, Tang Y, Lin J . Overexpression of thrombospondin-1 in stromal myofibroblasts is associated with tumor growth and nodal metastasis in gastric carcinoma. J Surg Oncol. 2012; 106(1):94-100. DOI: 10.1002/jso.23037. View

Seshasai S, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N . Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011; 364(9):829-841. PMC: 4109980. DOI: 10.1056/NEJMoa1008862. View

10.

Knol M, VanderWeele T . Recommendations for presenting analyses of effect modification and interaction. Int J Epidemiol. 2012; 41(2):514-20. PMC: 3324457. DOI: 10.1093/ije/dyr218. View

11.

Vandenbroucke J, von Elm E, Altman D, Gotzsche P, Mulrow C, Pocock S . Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology. 2007; 18(6):805-35. DOI: 10.1097/EDE.0b013e3181577511. View

12.

Samani A, Yakar S, LeRoith D, Brodt P . The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr Rev. 2006; 28(1):20-47. DOI: 10.1210/er.2006-0001. View

13.

Onitilo A, Engel J, Glurich I, Stankowski R, Williams G, Doi S . Diabetes and cancer I: risk, survival, and implications for screening. Cancer Causes Control. 2012; 23(6):967-81. PMC: 4138802. DOI: 10.1007/s10552-012-9972-3. View

14.

Fitzgerald S, Sheehan K, OGrady A, Kenny D, OKennedy R, Kay E . Relationship between epithelial and stromal TRIM28 expression predicts survival in colorectal cancer patients. J Gastroenterol Hepatol. 2013; 28(6):967-74. DOI: 10.1111/jgh.12157. View

15.

Chen W, Zheng R, Baade P, Zhang S, Zeng H, Bray F . Cancer statistics in China, 2015. CA Cancer J Clin. 2016; 66(2):115-32. DOI: 10.3322/caac.21338. View

16.

Karimi P, Islami F, Anandasabapathy S, Freedman N, Kamangar F . Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev. 2014; 23(5):700-13. PMC: 4019373. DOI: 10.1158/1055-9965.EPI-13-1057. View

17.

Chen K, Yang D, Li X, Sun B, Song F, Cao W . Mutational landscape of gastric adenocarcinoma in Chinese: implications for prognosis and therapy. Proc Natl Acad Sci U S A. 2015; 112(4):1107-12. PMC: 4313862. DOI: 10.1073/pnas.1422640112. View

18.

Matsubara J, Hirashima Y, Yamada Y . [Impact of HER2, EGFR, IGF-1R, and VEGFR expressions on the outcome of chemotherapy for advanced gastric cancer]. Gan To Kagaku Ryoho. 2010; 37(8):1489-96. View

19.

Takahashi T, Saikawa Y, Kitagawa Y . Gastric cancer: current status of diagnosis and treatment. Cancers (Basel). 2013; 5(1):48-63. PMC: 3730304. DOI: 10.3390/cancers5010048. View

20.

Chen B, Lin X, Chen G, Hu D, Zhu Q, Shi Y . [Expression of long non-coding RNA SNHG8 in Epstein-Barr virus-related gastric cancer and clinical outcome]. Zhonghua Bing Li Xue Za Zhi. 2017; 46(2):84-87. DOI: 10.3760/cma.j.issn.0529-5807.2017.02.004. View